Patent · US Expired

3',3-N-bis-substituted macrolide LHRH antagonists

US5972898A · kind A · utility

0Cited by

1References

16Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Daryl Sauer · Pleasant Prairie, US
Fortuna Haviv · Rehovot, IL
John T. Randolph · Libertyville, US
Nicholas A. Mort · Waukegan, US
Christopher R. Dalton · Mundelein, US
Milan Bruncko · Libertyville, US
Michele A. Kaminski · Beach Park, US
Bradley W. Crawford · Gurnee, US
Lisa M. Frey · Mundelein, US
Jonathan Greer · Chicago, US

Key dates

Filing date	Mar 27, 1998
Grant date	Oct 26, 1999
Priority date	—
Expiry date	Mar 27, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are 3',3'-N-bisdesmethyl-3',3'-N-bis-substituted-6-O-methyl-11-deoxy-11,12-cyc lic carbamate erythromycin A derivatives which are antagonists of lutenizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.